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accrued experience evidenced the need of an information system
available at National level providing efﬁcient timely communi-
cations and data sharing for appropriate actions. A WEBGIS
developed by the Italian EIA National Reference Centre (NRCEIA)
was tested in 2015 at Regional level (Latium) to: ensure real time
tracking of EIA case location; trigger immediate alerts on new
cases and outbreaks; allow risk evaluation and management of
equid movements; provide practical tools for Veterinary Ofﬁcers
for surveillance, control or emergency actions in infected areas.
The WEBGIS was also speciﬁcally oriented as a practical instru-
ment for outbreak management. The Geo-portal was developed
using open-source geographical layers (Base map aerials, topog-
raphy, streets and municipalities borders) and programming
softwares with the geodatabase automatically fed using ofﬁcial
sources of structured data relative to farm registration and loca-
tion, conﬁrmed cases and ofﬁcially notiﬁed outbreaks through
dedicated web-services, providing an interactive, uniﬁed SOAP
interface display to users with daily updating. By accessing to
CRAIE-WEBGIS webpage (http://195.45.99.77/craie/), the Local,
Regional and National Veterinary Authorities can generate and
display the list and location of the conﬁrmed cases and the
notiﬁed outbreaks. Details on outbreak status (i.e. from suspected
to conﬁrmed or to extinguished, species and number of in-
dividuals involved) are daily tracked and available. Controlling
the retrospective geodatabase, it is possible to discriminate inci-
dent from recurrent cases and outbreaks as also activate the
display of the areas at risk around the active outbreaks, allowing
the automatic listing of all the farms registered within a deﬁned
surveillance buffer/area, where targeted serological and syn-
dromic surveillance must be put in place. Further to the dynamic
tools, the CRAIE-WEBGIS also releases periodic static reports (lists
and maps) relative to outbreak characteristics and location,
allowing a timely supervision of the actions undertaken and a
preliminary evaluation of the epidemiological trends. The CRAIE-
WEBGIS experience in Latium contributed to reduce uncertainty,
provide timely and effective actions, raising the biosecurity level
of the equid population. Its extension at a national level will
support the country surveillance, data collection and outbreak
tracking, allowing the derived epidemiological data to be used for
risk assessment and management and timely evidence-based
interventions.
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As in other mammals, horses can be affected by several fungal
infections. However, only a small number of these are known to
cause clinical disease and death. Multiple species of fungus are
ubiquitous in the environment, and thus horses can acquire the
fungal spores by inhalation, ingestion or contact (skin and mu-
cosa). In addition, there is a predisposition for disease develop-
ment related with the environmental conditions and the host’simmune conditions. The aim of this report is to describe the
features and clinical ﬁndings in a series of equine mortalities
occurred in a Thoroughbred and Quarter Mile horse breeding
farm located in Ca~nuelas, Buenos Aires Province, Argentina. The
affected population consisted of 20 nursing foals (between 3 to 6
months of age). They were allowed to graze freely on natural
pasture, without supplementation of dry (hay) or other com-
mercial equine feed. Due to the excessive rainfall, the animals
were frequently moved over different paddocks for food access.
During February-April 2014, 7 foals and 1 mare showed hyper-
thermia, depression, edema, profuse diarrhea, colic, serous nasal
secretion and mucous membrane congestion. These clinical signs
were followed by the development of ulcerative lesions with
posterior necrosis of nasal septum mucosa. Even though all the
affected animals received analgesic, antipyretic, antidiarrheal and
different antibiotics treatment, no improvement was obtained.
The course of the disease was variable between 2 and 45 days.
Ultrasonography revealed the presence of Rhodococcus equi (R.
equi)-like lesions (abscesses) in the lungs in 6 out of the 7 affected
foals. Nasal turbinates swabs (NS), tracheal washes (TW), whole
blood to obtain peripheral blood mononuclear cells (PMBC) and
serum samples were collected for microbiological studies
(virology, bacteriology and mycology). Exhaustive necropsy, tis-
sue samples collection and histopathology and microbiology
studies were performed. No virus was detected in NS or PBMC. No
antibodies against Burkhordelia mallei (Glanders) were identi-
ﬁed. At necropsy, the most consistent lesions were ulcers and
necrosis of nasal septum; similar lesions but of lesser extent were
also found in the tongue, palate and along the gastrointestinal
tract. Lesions compatibles with those induced by R. equi were not
observed in the lung. Histopathology revealed severe acute
multifocal necrotizing interstitial pneumonia; severe chronic
multifocal necrotizing rhinitis with vasculitis and intralesional
fungal hyphae in nasal turbinates, and mild to severe suppurative
inﬂammation with marked lymphoid depletion in colon. The
fungi in the nasal turbinates were morphologically consistent
with Zygomycetes (Mucor, Basidiobolus, Conidiobolus) or
Oomycetes (Pythiumsp). Unfortunately, the etiology of the dis-
ease and death of these horses could not be determined; the
presence of fungus-like microorganisms in the lesions could be a
result of secondary infection due to intestinal injury.
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Anthrax is a highly pathogenic zoonotic disease caused by Bacillus
anthracis, a Gram positive spore-forming bacillus. Although it
primarily affects herbivores, other mammals, including humans,
can be affected. Animals may have at least three clinical pre-
sentations, hyperacute, acute, and subacute or chronic; horses
almost always develop the acute form, generally manifesting
throatlatch swelling, fever, dispnoea, rapid onset of septicemia,
disseminated intravascular coagulation and shock. Bleeding from
natural oriﬁces is common in most species. The importance in
public health lies in its zoonotic potential. Three forms of pre-
sentation have been described in humans: cutaneous, respiratory
and digestive, depending on the route of exposure. Lethality in
humans is extremely high without rapid detection and treatment.
In December 2013, an adult crossbred work horse, belonging to
persons of extremely limited resources, presented at the Uni-
versidad Austral de Chile's Veterinary Hospital due to sudden
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there was no vaccination history. Clinical examination revealed
severe depression, generalized muscle twitching, severe tachy-
cardia and tachypnea, hypothermia, hypovolemia, severe edema
of the glottis, and hypotonia of the anal sphincter. During the
initial assessment, the patient developed bilateral epistaxis. Faced
with signs of respiratory obstruction (due to retropharyngeal
edema and lymphadenopathy) and severe coagulopathy, the an-
imal was euthanized. Necropsy revealed blood incoagulability,
multiple organ congestion and retromandibular edema. Parotid
lymph node samples were taken, and anthrax was conﬁrmed by
microbiological culture of Bacillus anthracis within 72 hours of
death. With this diagnosis, the competent national health service
was immediately notiﬁed for coordination of post-exposure in-
terventions. Four people had been directly exposed to the animal
(two owners and four university employees; two veterinarians
were exposed to spore inhalation during necropsy), and 7 others
were determined to have been on the premises. The health ser-
vice provided health monitoring guidelines and antibiotic pro-
phylaxis (ciproﬂoxacin 500mg twice daily) for a period of 60 days
for all exposed owners and personnel. All directly exposed in-
dividuals' clothing and residual biological material was inciner-
ated. The equine veterinary hospital was emptied of all animals
(none of which were exposed to the patient), and contaminated
premises were thrice disinfected with quaternary ammonia and
glutaraldehyde. There were no manifestations of disease in the
people involved, and no ulterior equine cases. Although anthrax is
endemic in Chile, with 37 human cases reported between 2000-
2009, animal vaccination is rare and no equine cases have been
described since 1990 (Araya et al, 1990). This case is noteworthy
on account of the rare occurrence of the disease, and because
rapid cooperation of veterinarians and the national health service
permitted continued monitoring and prophylactic treatment of
the university personnel and of the poorly educated owners of the
horse, thereby avoiding human cases. Thus, urgent mandatory
reporting of suspected cases should be emphasized.
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Equine grass sickness (EGS; Figure 1) is a frequently fatal neuro-
degenerative disease affecting grazing equids, predominantly in
northern European and South American countries. It is hypoth-
esised that EGS represents a toxico-infectious form of botulism,
where a combination of risk factors triggers in-vivo production of
Clostridium botulinum type C toxins by bacteria present within the
gastrointestinal tract. Several previous studies have reported a
protective effect of natural immunity to C. botulinum type C. To
date, no vaccine is available for EGS prevention. This study aimed
to determine safety and immunogenicity of a modern C. botuli-
num type C vaccine intended for EGS prevention, in the target
species. An experimental randomised, triple-blinded, placebo-
controlled safety study of a C. botulinum type C bacterin-toxoid
vaccine was undertaken in 15 foals (aged 10-14 weeks). Foalswere randomly assigned to one of two groups at a 1:2 ratio, and
received either the test vaccine (n¼10) or placebo (sterile saline)
(n¼5), with four intramuscular injections administered at 21 days
intervals. All personnel performing animal care, clinical exami-
nations and laboratory analyses were unaware of the foals’
vaccination status. Health assessments were performed daily
from day -2 until day 70, and clinical assessments were per-
formed daily on the day of each injection and six days subse-
quently. To evaluate vaccine immunogenicity, serum samples
were obtained on days 0, 14, 21, 35, 42, 56, 63, 77, and 91 and
analysed using an indirect C. botulinum type C ELISA. Analysis of
variance and Student's t-test or Wilcoxon signed rank tests were
used to conduct intra- and inter-group comparisons, respectively.
No immediate post-vaccination adverse events or systemic
adverse reactions were observed during the study. Local site re-
action was limited to one vaccinated foal. On day 0, there was no
difference in mean ELISA optical density (OD) between treatment
groups (p¼0.73). There was a signiﬁcant increase in C. botulinum
type C antibody levels within the vaccinated group, with pre-
V1<post-V2<post-V3, and all vaccinated animals had sero-
converted following V3 (Figure 2). Antibody levels remained low
in the placebo-treated control group. This study demonstrates the
ﬁrst evidence of safety and immunogenicity of a C. botulinum
type C equine vaccine, which warrants further evaluation as a
candidate vaccine for EGS prevention. The safety study was fun-
ded by Neogen Corporation.
Figure 1. Chronic EGS case exhibiting clinical signs of depression, weight
loss and base-narrow stance.
Figure 2. Antibody response to C. botulinum type C vaccination: fold change
in ELISA OD compared to day 0 (ELISA OD ratio) for vaccinated and control
groups.
